Skip to content

Secretin Activates Human Brown Fat and Induces Satiation.

Secretin Increases Glucose Uptake in Human Brown Adipose Tissue and Induces Satiation.

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03290846
Acronym
GUTBAT
Enrollment
23
Registered
2017-09-25
Start date
2016-08-02
Completion date
2019-11-30
Last updated
2019-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

15 healthy males will be studied with PET/CT, using FDG to investigate glucose metabolism, and radiowater to investigate perfusion. One scan will be performed in controlled cold exposure, to see whether subjects have cold activated brown adipose tissue. Two scans will be performed in room temperature conditions, where all subjects are blinded and randomised to receive placebo and secretin hydrochloride. PET/CT scans will be analysed blinded. 20 healthy males will also be studied with fMRI, in order to investigate brain activity responses to appetizing versus bland foods. This study will be conduced on the same patients as the PET/CT study, but additional subjects with same inclusion and exclusion criteria will be recruited. Two fMRI scans will be performed in room temperature conditions, where all subjects are blinded and randomised to receive placebo and secretin hydrochloride. fMRI scans will be analysed blinded.

Detailed description

The PET/CT study will consist of 15 healthy, normal weight males, between ages 18-65. A 2-hour oral glucose tolerance test is performed on screening day. Calorimetry data is collected at baseline (resting and fasting) condition. Three PET/CT scans on three different days will be performed to all 15 study subjects. Radiowater (15O)-H2O is used to study perfusion and FDG ((F18)-FDG) to study glucose metabolism. After radiowater, PET data is collected from the neck area for 6 minutes. After FDG, PET data is collected for 40 minutes on the neck area, 15 minutes on the chest, 15 minutes on the abdomen and 15 minutes on the brain. Calorimetry is collected during the entire scan. Blood samples are collected during scans for metabolites and for a plasma activity curve. One scan is performed during controlled, cold exposure. This is done to investigate, whether patients have cold activated brown adipose tissue. After this, subjects will undergo two room temperature condition scans on different days, where participants are single-blinded and randomised to receive placebo (saline) or secretin (secretin hydrochloride) infusions. All scans are done in fasting conditions. After subjects have fed at the PET centre, calorimetry data is collected on all days. A full body MRI will be performed on a separate day with the Dixon-method. After scanning visits, brown adipose tissue biopsies will be taken from volunteers by a plastic surgeon. These samples are analysed in Munich. Dynamic scan data is analysed with the Carimas program, using Patlak plot. Analysis is performed blinded. Further statistics analysis is done with SPSS. The fMRI study will consist of 20 healthy, normal weight males, between ages 18-65. Subjects who underwent PET/CT scanning will be recruited for this study, as well as an additional group of subjects with the same inclusion and exclusion criteria. A 2-hour oral glucose tolerance test is performed on screening day for additional subjcts. Two fMRI scans are conducted in room temperature after overnight fast on separate days. Subjects are randomized and blinded to receive placebo and secretin hydrochloride on separate days. Data on brain activity while viewing appetizing versus bland food images is collected during scan. After scanning subjects are given a meal and then followed up for two hours. Data on subjective satiety will be collected with a visual analogue scale questionnaire on nine different timepoints during the day: in preprandial, prandial and postprandial conditions. Functional MRI data is analyzed with Matlab. Analysis is performed blinded. Satiety score is analzed with SPSS.

Interventions

DRUGSaline Solution

Randomized, single-blinded saline infusion.

DRUGSecretin Human

Randomized, single-blinded secretin hydrochloride infusion.

OTHERCold exposure

All subjects will undergo a cold exposure PET scan.

Sponsors

Technical University of Munich
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

Participants receive drug and placebo infusion without knowing which day is which.

Intervention model description

Single blinded randomised study, secretin infusion is given on one day, saline infusion on an other day.

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy normal weight

Exclusion criteria

* cardiovascular disease, diabetes * smoking

Design outcomes

Primary

MeasureTime frameDescription
Secretin activates brown fatEffect within one hourSecretin increases brown adipose tissue glucose uptake compared to placebo. This is studied with PET/CT, using a glucose tracer.
Secretin induces satiationEffect within one hourSecretin attenuates brain activity, when subjects are viewing palatable vs. non-palatable food images.

Secondary

MeasureTime frameDescription
Secretin reduces food consumption.Within three daysData on food consumption is collected directly after scan, as well as with food diaries. Calory intake is measured and comparisons are made between secretin and placebo.
Secretin induces satietyEffect within three hoursComposite satiety score is measured by visual analogue scale questionnaire
Secretin increases whole body energy expenditureEffect within two hoursSecretin increases whole body energy expenditure compared to placebo. Data is collected durin PET/CT scans by indirect calorimetry.

Other

MeasureTime frameDescription
Secretin induces changes in biomarkers and metabolites.Within two hoursSerum samples are collected during PET/CT scan and analyzed.
Brown adipose tissue biopsies.Within 2 monthsBrown adipose tissue biopsy samples are collected from subjects and analyzed.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026